Author: healthadmin

When a bacterial infection no longer responds to antibiotics, doctors have few treatment options. Phage viruses that naturally infect and kill bacteria have long intrigued clinicians as potential weapons against these infections. But converting these tiny bacteria hunters into drugs is slow and unreliable. New efforts leveraging engineering and artificial intelligence could change this. The Gladstone Institute has received an initial grant of $2 million from the National Institute of Allergy and Infectious Diseases (NIAID), with additional funding totaling up to $10 million available over the planned five-year project period. This grant will establish the PhAIge Therapies Center, a research…

The Joint Commission on Monday announced the launch of a new artificial intelligence certification program that provides a blueprint for responsible AI implementation in health care, touting it as a “first of its kind.” According to the Joint Commission, the Responsible Use of AI in Healthcare (RUAIH) certification is a voluntary program for organizations focused on the “safe, reliable, transparent, and ethical use” of technology. This program does not validate or certify individual products or tools. Certification standards are focused on five areas: governanceEffective data managementRisk and bias reductionMonitoring, evaluation, and verification of safety performance, effectiveness, and responsible useTransparency, education…

Millions of Americans currently take GLP-1 drugs such as Ozempic and Wigovy for weight loss. But along with fat, many people are quietly losing something else: muscle. Unlike fat, muscle doesn’t come back quickly, so muscle loss can negatively impact your strength, mobility, and overall health. Now, researchers at Stanford Medicine have discovered that an existing drug already in clinical trials for age-related muscle loss may be able to alleviate this problem. Young adult mice given the drug in combination with GLP-1 showed improved muscle regeneration and muscle strength recovery after muscle injury without compromising fat loss. There is…

A group of researchers at the Medical University of South Carolina (MUSC) recently developed a new stem cell therapy with the remarkable ability to reverse new-onset type 1 diabetes (T1D) in mouse models. Dr. Hongjun Wang, associate director of the South Carolina Clinical Translational Research (SCTR) Institute Pilot Program and co-scientific director of the Cell Therapy Center, led the team. Co-author Dr. Hua Wei. Dr. Kim Ju-dong; and Dr. Wenyu Gou, along with other collaborators, conducted the bulk of the research to establish these findings, and the results were published in the journal. molecular therapy. This research study marks a…

A randomized controlled trial conducted at the University of Maryland School of Medicine found that a 5-minute session of Proximity Intercessory Prayer (PIP), in-person prayer performed by trained volunteers, significantly reduced pain and anxiety in primary care patients compared to a music control group. The findings were published in the May/June 2026 issue of the journal. Family medicine annual reportsuggest that proximal intercessory prayer may provide a practical, nonpharmacological complement to conventional care, especially for underserved populations. Researchers enrolled 180 patients at a university family medicine clinic who reported clinically significant pain (score 4 or higher on a 0-10 scale)…

Imagine a pile of trash the size of Manhattan and taller than one and a half Empire State Buildings. This is the amount of plastic waste the world is projected to produce every year by 2050 if nothing is done to change course. It’s easy to think of recycling as a solution, but the vast majority of plastic waste currently ends up in landfills or worse. A large amount of plastic waste is shipped overseas. In new research, my colleagues and I analyzed what happens when plastic waste is shipped to low- and middle-income countries. Open burning is a common…

A large, real-world study by pharmacy researchers at the University of California, Irvine has uncovered serious blood-related side effects associated with antibody-drug conjugates, an increasingly important targeted cancer therapy. Over the years, many new ADC therapies have been approved for the treatment of various types of cancer. Research published in journals canceranalyzed treatment data from 3,511 patients across six University of California medical centers. They found that some ADCs are associated with significant rates of severe neutropenia (dangerously low levels of infection-fighting white blood cells) and associated complications, including febrile neutropenia, a potentially life-threatening condition that involves hospitalization, intensive care…

Millions of people who visit Grand Canyon National Park each year stop at one of the park’s water stations. Some people stand on the rim and see the canyon for the first time, refilling their water bottles before continuing their journey. Others are far below, hiking through extreme heat, refilling reservoirs and dousing themselves with water to protect themselves from dehydration and heat stroke. Its water comes from a single source. It’s Roaring Springs, a spring that gushes out of a cave on the North Rim. Hikers can hear and catch glimpses of spring from the North Kaibab Trail, but…

For Roche, the Phase 3 failure in first-line breast cancer does not eliminate the blockbuster potential of its oral SERD drug gylidestrant, despite increased competition. Indeed, the results from the failed PerseverERA trial for primary treatment of HR-positive, HER2-negative metastatic breast cancer give Roche confidence in a new study testing giledestrant in combination with a CDK4/6 inhibitor as an adjuvant treatment for early-stage breast cancer, Roche Deputy Chief Medical Officer Stephen Frings, MD, told Fierce in an interview. “What we’re still seeing is a very attractive separation of the curves (…) that clearly shows there is a therapeutic effect,” Frings…

Cancer cells require large amounts of energy to survive and multiply. To generate that energy, they rely on structures within the cell called mitochondria. Mitochondria are often referred to as the “powerhouses” of the cell. Unlike healthy cells, cancer cells rely heavily on specialized helper proteins to maintain mitochondrial function even under the high stress of rapid proliferation. This dependency creates opportunity. If we can disrupt that process in a targeted way, we might be able to damage cancer cells while sparing healthy tissue. ” Anthony Olszanski, MD, RPh, Vice Chair for Clinical Research in Hematology-Oncology and…